SIS
MRNA icon

Strategic Investment Solutions’s Moderna MRNA Stock Holding History

Strategic Investment Solutions’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.2K Buy
+874
New +$45.2K 0.01% 247
2024
Q3 		– Sell
-25
Closed -$9.62K – 684
2024
Q2 		$9.62K Buy
+25
New +$3.16K ﹤0.01% 349
2023
Q4 		– Sell
-945
Closed -$105K – 1163
2023
Q3 		$105K Buy
945
+930
+6,200% +$104K ﹤0.01% 551
2023
Q2 		$1.76K Hold
15
– – ﹤0.01% 761
2023
Q1 		$2.3K Buy
+15
New +$2.48K ﹤0.01% 860

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Strategic Investment Solutions's MRNA Position: Q2 2026 in Review

Strategic Investment Solutions opened a new position in Moderna (MRNA) in Q2 2026: 874 shares worth $61.2K. The stake represents 0.01% of the portfolio and ranks #247 among its holdings. This is a return to the name: Strategic Investment Solutions previously reported a position in MRNA as recently as Q2 2024.

Strategic Investment Solutions first reported a position in MRNA in Q1 2023 and has held it in 5 quarters since. The position peaked at $105K in Q3 2023. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Strategic Investment Solutions held 874 shares of Moderna worth $61.2K as of Q2 2026.
  • Moderna was a new Strategic Investment Solutions position in Q2 2026.
  • Moderna made up 0.01% of Strategic Investment Solutions's portfolio in Q2 2026, its #247 holding.
  • Strategic Investment Solutions first reported a position in Moderna in Q1 2023 and has held it in 5 quarters since.
  • Strategic Investment Solutions's Moderna position peaked at $105K in Q3 2023.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.